VERU INC. Selling, General and Administrative Expense
VERU INC. (VERU) reported Selling, General and Administrative Expense of $5.01 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2025-08-12
- VERU INC. selling, general and administrative expense for the quarter ending 2025-06-30 was $5.01M, a 13.75% decline year-over-year.
- VERU INC. selling, general and administrative expense for the quarter ending 2025-03-31 was $5.16M, a 12.52% decline year-over-year.
- VERU INC. selling, general and administrative expense for the quarter ending 2024-12-31 was $5.23M, a 21.42% decline year-over-year.
- VERU INC. selling, general and administrative expense for the quarter ending 2024-09-30 was $12.82M, a 89.23% increase year-over-year.
- VERU INC. selling, general and administrative expense for fiscal 2024 was $31.18M, a 35.11% decline from fiscal 2023.
- VERU INC. selling, general and administrative expense for fiscal 2023 was $48.06M, a 11.30% increase from fiscal 2022.
- VERU INC. selling, general and administrative expense for fiscal 2022 was $43.18M, a 108.89% increase from fiscal 2021.
- VERU INC. selling, general and administrative expense for fiscal 2021 was $20.67M, a 42.57% increase from fiscal 2020.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $5.01M 10-Q · filed 2025-08-12 | $10.17M derived: sum of 2 quarters · filed 2025-08-12 | $15.40M 10-Q · filed 2025-08-12 | $28.22M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2025-03-31 | $5.16M 10-Q · filed 2025-05-08 | $10.39M 10-Q · filed 2025-05-08 | $23.21M derived: sum of 3 quarters · filed 2025-05-08 | $29.02M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-12-31 | $5.23M 10-Q · filed 2025-02-13 | $18.05M derived: sum of 2 quarters · filed 2025-02-13 | $23.86M derived: sum of 3 quarters · filed 2025-08-12 | $29.76M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-09-30 | $12.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $18.63M derived: sum of 2 quarters · filed 2025-08-12 | $24.53M derived: sum of 3 quarters · filed 2025-08-12 | $31.18M 10-K · filed 2024-12-16 | ||||
| 2024-06-30 | $5.81M 10-Q · filed 2025-08-12 | $7.51M 10-Q · filed 2024-08-08 | $11.71M derived: sum of 2 quarters · filed 2025-08-12 | $18.36M 10-Q · filed 2025-08-12 | $23.39M 10-Q · filed 2024-08-08 | $25.14M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $5.90M 10-Q · filed 2025-05-08 | $7.58M 10-Q · filed 2024-05-08 | $12.56M 10-Q · filed 2025-05-08 | $15.88M 10-Q · filed 2024-05-08 | $19.33M derived: sum of 3 quarters · filed 2025-05-08 | $30.23M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $6.65M 10-Q · filed 2025-02-13 | $8.30M 10-Q · filed 2024-04-01 | $13.43M derived: sum of 2 quarters · filed 2025-02-13 | $24.33M derived: sum of 3 quarters · filed 2025-02-13 | $37.16M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $6.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $17.68M derived: sum of 2 quarters · filed 2024-12-16 | $30.51M derived: sum of 3 quarters · filed 2024-12-16 | $48.06M 10-K · filed 2024-12-16 | ||||
| 2023-06-30 | $10.90M 10-Q · filed 2024-08-08 | $23.74M derived: sum of 2 quarters · filed 2024-08-08 | $41.28M 10-Q · filed 2024-08-08 | $59.57M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $12.83M 10-Q · filed 2024-05-08 | $30.38M 10-Q · filed 2024-05-08 | $48.67M derived: sum of 3 quarters · filed 2024-05-08 | $59.43M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $17.55M 10-Q · filed 2024-04-01 | $35.84M derived: sum of 2 quarters · filed 2024-04-01 | $46.60M derived: sum of 3 quarters · filed 2024-04-01 | $54.00M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-09-30 | $18.29M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $29.05M derived: sum of 2 quarters · filed 2024-04-01 | $36.45M derived: sum of 3 quarters · filed 2024-04-01 | $43.18M 10-K/A · filed 2024-04-01 | $43.17M 10-K · filed 2022-12-05 | |||
| 2022-06-30 | $10.76M 10-Q/A · filed 2023-11-15 | $10.76M 10-Q · filed 2022-08-11 | $18.16M derived: sum of 2 quarters · filed 2023-11-15 | $24.89M 10-Q/A · filed 2023-11-15 | $24.88M 10-Q · filed 2022-08-11 | $30.81M derived: sum of 4 quarters · filed 2023-11-15 | ||
| 2022-03-31 | $7.40M 10-Q · filed 2023-05-11 | $7.40M 10-Q · filed 2022-05-12 | $14.13M 10-Q · filed 2023-05-11 | $14.12M 10-Q · filed 2022-05-12 | $20.05M derived: sum of 3 quarters · filed 2023-05-11 | $25.61M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $6.72M 10-Q · filed 2023-02-09 | $12.65M derived: sum of 2 quarters · filed 2023-02-09 | $18.20M derived: sum of 3 quarters · filed 2023-02-09 | $23.01M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-09-30 | $5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $11.48M derived: sum of 2 quarters · filed 2022-12-05 | $16.29M derived: sum of 3 quarters · filed 2022-12-05 | $20.67M 10-K · filed 2022-12-05 | ||||
| 2021-06-30 | $5.56M 10-Q · filed 2022-08-11 | $10.36M derived: sum of 2 quarters · filed 2022-08-11 | $14.75M 10-Q · filed 2022-08-11 | $18.21M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $4.81M 10-Q · filed 2022-05-12 | $9.19M 10-Q · filed 2022-05-12 | $12.65M derived: sum of 3 quarters · filed 2022-05-12 | $16.13M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $4.38M 10-Q · filed 2022-02-09 | $7.85M derived: sum of 2 quarters · filed 2022-02-09 | $11.32M derived: sum of 3 quarters · filed 2022-02-09 | $15.13M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-09-30 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $6.94M derived: sum of 2 quarters · filed 2021-12-02 | $10.74M derived: sum of 3 quarters · filed 2021-12-02 | $14.50M 10-K · filed 2021-12-02 | ||||
| 2020-06-30 | $3.48M 10-Q · filed 2021-08-12 | $7.28M derived: sum of 2 quarters · filed 2021-08-12 | $11.03M 10-Q · filed 2021-08-12 | $14.72M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $3.81M 10-Q · filed 2021-05-12 | $7.56M 10-Q · filed 2021-05-12 | $11.24M derived: sum of 3 quarters · filed 2021-05-12 | $14.79M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $3.75M 10-Q · filed 2021-02-10 | $7.44M derived: sum of 2 quarters · filed 2021-02-10 | $10.99M derived: sum of 3 quarters · filed 2021-02-10 | $14.81M derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-09-30 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $7.23M derived: sum of 2 quarters · filed 2020-12-10 | $11.05M derived: sum of 3 quarters · filed 2020-12-10 | $14.35M 10-K · filed 2020-12-10 | ||||
| 2019-06-30 | $3.55M 10-Q · filed 2020-08-13 | $7.37M derived: sum of 2 quarters · filed 2020-08-13 | $10.66M 10-Q · filed 2020-08-13 | $14.60M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $3.82M 10-Q · filed 2020-05-13 | $7.12M 10-Q · filed 2020-05-13 | $11.05M derived: sum of 3 quarters · filed 2020-05-13 | $15.08M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $3.29M 10-Q · filed 2020-02-12 | $7.23M derived: sum of 2 quarters · filed 2020-02-12 | $11.26M derived: sum of 3 quarters · filed 2020-02-12 | $15.07M derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-09-30 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $7.96M derived: sum of 2 quarters · filed 2019-12-12 | $11.78M derived: sum of 3 quarters · filed 2019-12-12 | $14.81M 10-K · filed 2019-12-12 | $14.82M 10-K · filed 2018-12-13 | |||
| 2018-06-30 | $4.02M 10-Q · filed 2019-08-08 | $4.03M 10-Q · filed 2018-08-14 | $7.84M derived: sum of 2 quarters · filed 2019-08-08 | $10.87M 10-Q · filed 2019-08-08 | $10.88M 10-Q · filed 2018-08-14 | $14.11M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $3.82M 10-Q · filed 2019-05-15 | $3.82M 10-Q · filed 2018-05-11 | $6.85M 10-Q · filed 2019-05-15 | $6.85M 10-Q · filed 2018-05-11 | $10.09M derived: sum of 3 quarters · filed 2019-05-15 | $13.27M derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $3.03M 10-Q · filed 2019-02-13 | $2.95M 10-Q · filed 2018-02-14 | $6.27M derived: sum of 2 quarters · filed 2019-02-13 | $9.45M derived: sum of 3 quarters · filed 2019-02-13 | $12.00M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-09-30 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $6.43M derived: sum of 2 quarters · filed 2018-12-13 | $8.97M derived: sum of 3 quarters · filed 2018-12-13 | $11.50M 10-K · filed 2018-12-13 | $11.02M 10-K · filed 2018-01-02 | |||
| 2017-06-30 | $3.18M 10-Q · filed 2018-08-14 | $3.13M 10-Q · filed 2017-08-09 | $5.73M derived: sum of 2 quarters · filed 2018-08-14 | $8.26M 10-Q · filed 2018-08-14 | $8.91M 10-Q · filed 2017-08-09 | $8.84M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $2.54M 10-Q · filed 2018-05-11 | $2.42M 10-Q · filed 2017-05-10 | $5.07M 10-Q · filed 2018-05-11 | $5.78M 10-Q · filed 2017-05-10 | $5.66M derived: sum of 3 quarters · filed 2018-05-11 | $8.02M derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $2.53M 10-Q · filed 2018-02-14 | $3.12M derived: sum of 2 quarters · filed 2018-02-14 | $5.48M derived: sum of 3 quarters · filed 2018-02-14 | $8.22M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | $586.89K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $2.95M derived: sum of 2 quarters · filed 2018-01-02 | $5.69M derived: sum of 3 quarters · filed 2018-01-02 | $8.66M 10-K · filed 2018-01-02 | ||||
| 2016-06-30 | $2.36M 10-Q · filed 2017-08-09 | $5.10M derived: sum of 2 quarters · filed 2017-08-09 | $8.07M 10-Q · filed 2017-08-09 | |||||
| 2016-03-31 | $2.74M 10-Q · filed 2017-05-10 | $5.71M 10-Q · filed 2017-05-10 | ||||||
| 2015-09-30 | $12.13M 10-K · filed 2018-01-02 | |||||||
| 2014-09-30 | $9.13M 10-K · filed 2016-12-12 | $9.14M 10-K · filed 2014-12-02 | ||||||
| 2013-09-30 | $7.49M 10-K · filed 2015-12-02 | $7.49M 10-K · filed 2013-12-03 | ||||||
| 2012-09-30 | $9.63M 10-K · filed 2014-12-02 | |||||||
| 2012-03-31 | $2.40M 10-Q · filed 2012-05-01 | $4.63M 10-Q · filed 2012-05-01 | $6.77M derived: sum of 3 quarters · filed 2013-12-03 | $8.02M derived: sum of 4 quarters · filed 2013-12-03 | ||||
| 2011-12-31 | $2.23M 10-Q · filed 2012-01-31 | $4.37M derived: sum of 2 quarters · filed 2013-12-03 | $5.62M derived: sum of 3 quarters · filed 2013-12-03 | $7.33M derived: sum of 4 quarters · filed 2013-12-03 | ||||
| 2011-09-30 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $3.39M derived: sum of 2 quarters · filed 2013-12-03 | $5.09M derived: sum of 3 quarters · filed 2013-12-03 | $6.54M 10-K · filed 2013-12-03 | $6.23M 10-K · filed 2011-12-02 | |||
| 2011-06-30 | $1.25M 10-Q · filed 2011-08-05 | $2.95M derived: sum of 2 quarters · filed 2012-05-01 | $4.40M 10-Q · filed 2011-08-05 | $6.19M derived: sum of 4 quarters · filed 2012-12-04 | ||||
| 2011-03-31 | $1.71M 10-Q · filed 2012-05-01 | $3.29M 10-Q · filed 2012-05-01 | $4.95M derived: sum of 3 quarters · filed 2012-12-04 | $5.87M derived: sum of 4 quarters · filed 2012-12-04 | ||||
| 2010-12-31 | $1.58M 10-Q · filed 2012-01-31 | $3.24M derived: sum of 2 quarters · filed 2012-12-04 | $4.16M derived: sum of 3 quarters · filed 2012-12-04 | |||||
| 2010-09-30 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $2.58M derived: sum of 2 quarters · filed 2012-12-04 | $6.57M 10-K · filed 2012-12-04 | $6.43M 10-K · filed 2011-12-02 | ||||
| 2010-06-30 | $922.02K 10-Q · filed 2011-08-05 | $4.91M 10-Q · filed 2011-08-05 | ||||||
| 2009-09-30 | $7.01M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |